Suppr超能文献

肥胖症的新疗法:对癌症预防和治疗的影响。

Novel Treatments for Obesity: Implications for Cancer Prevention and Treatment.

机构信息

Endocrine Unit, E.O. Ospedali Galliera, 16128 Genoa, Italy.

Division of Medical Oncology, E.O. Ospedali Galliera, 16128 Genoa, Italy.

出版信息

Nutrients. 2023 Aug 25;15(17):3737. doi: 10.3390/nu15173737.

Abstract

It is now established that obesity is related to a higher incidence of cancer during a lifespan. The effective treatment of obesity opens up new perspectives in the treatment of a relevant modifiable cancer risk factor. The present narrative review summarizes the correlations between weight loss in obesity and cancer. The current knowledge between obesity treatment and cancer was explored, highlighting the greatest potential for its use in the treatment of cancer in the clinical setting. Evidence for the effects of obesity therapy on proliferation, apoptosis, and response to chemotherapy is summarized. While more studies, including large, long-term clinical trials, are needed to adequately evaluate the relationship and durability between anti-obesity treatment and cancer, collaboration between oncologists and obesity treatment experts is increasingly important.

摘要

现在已经确定,肥胖与一生中更高的癌症发病率有关。肥胖的有效治疗为治疗相关可改变的癌症风险因素开辟了新的前景。本叙述性综述总结了肥胖与癌症之间的体重减轻相关性。探讨了肥胖治疗与癌症之间的现有知识,突出了其在临床环境中治疗癌症的最大潜力。总结了肥胖症治疗对增殖、凋亡和对化疗反应的影响的证据。虽然需要更多的研究,包括大型、长期的临床试验,以充分评估抗肥胖治疗与癌症之间的关系和持久性,但肿瘤学家和肥胖治疗专家之间的合作变得越来越重要。

相似文献

1
Novel Treatments for Obesity: Implications for Cancer Prevention and Treatment.
Nutrients. 2023 Aug 25;15(17):3737. doi: 10.3390/nu15173737.
3
Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management.
Curr Atheroscler Rep. 2022 Aug;24(8):643-654. doi: 10.1007/s11883-022-01041-7. Epub 2022 May 28.
4
Liraglutide in the treatment of obesity.
Expert Opin Biol Ther. 2014 Aug;14(8):1215-24. doi: 10.1517/14712598.2014.925870. Epub 2014 Jun 6.
5
8
Liraglutide: an injectable option for the management of obesity.
Ann Pharmacother. 2015 Aug;49(8):938-44. doi: 10.1177/1060028015586806. Epub 2015 May 18.
9
The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective.
Hum Reprod Update. 2019 Jul 1;25(4):504-517. doi: 10.1093/humupd/dmz019.
10
Liraglutide: A New Option for the Treatment of Obesity.
Pharmacotherapy. 2015 Oct;35(10):926-34. doi: 10.1002/phar.1639.

引用本文的文献

本文引用的文献

1
GLP-1 receptor agonist-associated tumor adverse events: A real-world study from 2004 to 2021 based on FAERS.
Front Pharmacol. 2022 Oct 25;13:925377. doi: 10.3389/fphar.2022.925377. eCollection 2022.
4
Effectiveness of weight loss interventions in breast cancer survivors: a systematic review of reviews.
BMJ Open. 2022 Oct 7;12(10):e062288. doi: 10.1136/bmjopen-2022-062288.
5
Obesity: a perfect storm for carcinogenesis.
Cancer Metastasis Rev. 2022 Sep;41(3):491-515. doi: 10.1007/s10555-022-10046-2. Epub 2022 Aug 30.
6
Effects of GLP-1 Receptor Agonists on Biological Behavior of Colorectal Cancer Cells by Regulating PI3K/AKT/mTOR Signaling Pathway.
Front Pharmacol. 2022 Aug 10;13:901559. doi: 10.3389/fphar.2022.901559. eCollection 2022.
7
GLP1R inhibits the progression of endometrial carcinoma through activation of cAMP/PKA pathway.
J Clin Lab Anal. 2022 Oct;36(10):e24604. doi: 10.1002/jcla.24604. Epub 2022 Aug 21.
8
Incretin based therapy and pancreatic cancer: Realising the reality.
World J Gastroenterol. 2022 Jul 7;28(25):2881-2889. doi: 10.3748/wjg.v28.i25.2881.
9
Brown-fat-mediated tumour suppression by cold-altered global metabolism.
Nature. 2022 Aug;608(7922):421-428. doi: 10.1038/s41586-022-05030-3. Epub 2022 Aug 3.
10
Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials.
Front Endocrinol (Lausanne). 2022 Jul 11;13:927859. doi: 10.3389/fendo.2022.927859. eCollection 2022.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验